Metagenomic next-generation sequencing for cryptococcal meningitis diagnosis: a single-center experience
Frontiers in Cellular and Infection Microbiology · 11.12.2025 · 15
DOI: 10.3389/fcimb.2025.1626290 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 11.12.2025. Verfasst von Zichun Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, High-Throughput Nucleotide Sequencing, Metagenomics, Cryptococcus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Cryptococcal meningitis (CM) is a devastating central nervous system infection with substantial mortality, particularly when diagnosis is delayed. This study aims to evaluate the diagnostic performance of metagenomic next-generation sequencing (mNGS) for CM detection in comparison with conventional tests.
Methods
We enrolled 23 consecutive patients with suspected CM at a tertiary center. All patients met a composite reference standard (CRS) based on CSF cryptococcal antigen (CrAg), CSF/sterile-site culture for Cryptococcus, or CNS histopathology; mNGS was excluded from the CRS. Primary outcomes were CRS-based sensitivity (computed only among CRS-positive patients who underwent each assay) and turnaround times (TATs); pairwise agreement metrics (PPA/NPA) between mNGS and conventional assays were estimated in co-tested subsets. Results mNGS identified Cryptococcus in 18/23 (78.3%) cases and detected viral co-pathogens (EBV/CMV/HIV-1) in 5 patients. CRS-based sensitivities were: CrAg LFA (CSF) 83.3% (5/6), Alcian blue 72.7% (16/22), India ink 50.0% (3/6), and CSF culture 66.7% (8/12). Pairwise agreement favored mNGS against culture and CrAg (e.g., PPA 100% vs culture 8/8] and vs CSF CrAg [5/5]), with limited NPA where denominators were small. Median (IQR) TATs were 0.5 (0.5–0.5) days for CrAg LFA, 1 (0.5–1) day for India ink, 5 (3–8) days for first positive culture, and 2 (1–4) days for mNGS.
Conclusion
CSF mNGS complements CrAg, microscopy, and culture by increasing Cryptococcus detection and revealing mixed infections, with particular utility in atypical, pretreated, or complex hosts. Larger studies are warranted to validate clinical utility and define optimal integration with existing workflows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Zitieren
APA
Zhao, Z., Zhang, Y., Fu, J., & Yu, L. (2025). Metagenomic next-generation sequencing for cryptococcal meningitis diagnosis: a single-center experience. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1626290
Vancouver
Zhao Z, Zhang Y, Fu J, Yu L. Metagenomic next-generation sequencing for cryptococcal meningitis diagnosis: a single-center experience. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1626290
BibTeX
@article{Zhao2025,
author = {Zhao, Zichun and Zhang, Yu and Fu, Jinsheng and Yu, Lili},
title = {Metagenomic next-generation sequencing for cryptococcal meningitis diagnosis: a single-center experience},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1626290}
}
EUVIMED